BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14633142)

  • 1. Amlodipine reverses the elevation in [Ca2+]i and the impairment of phagocytosis in PMNLs of NIDDM patients.
    Krol E; Agueel R; Banue S; Smogorzewski M; Kumar D; Massry SG
    Kidney Int; 2003 Dec; 64(6):2188-95. PubMed ID: 14633142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of amlodipine therapy on the monoclonal antibody 3G8-induced calcium signal in polymorphonuclear leukocytes of hemodialysis patients.
    Ahmed A; Krol E; Smogorzewski M; Massry SG
    Am J Nephrol; 1999; 19(4):505-8. PubMed ID: 10460943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of the effect of nifedipine therapy and its discontinuation on [Ca2+]i and phagocytosis of polymorphonuclear leukocytes from hemodialysis patients.
    Alexiewicz JM; Smogorzewski M; Gill SK; Akmal M; Massry SG
    Am J Nephrol; 1997; 17(1):12-6. PubMed ID: 9057947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amlodipine prevents and reverses the elevation in [Ca2+]i and the impaired phagocytosis of PMNL of diabetic rats.
    Seyrek N; Marcinkowski W; Smogorzewski M; Demerdash TM; Massry SG
    Nephrol Dial Transplant; 1997 Feb; 12(2):265-72. PubMed ID: 9132643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfunction of polymorphonuclear leukocytes in uremia: role of parathyroid hormone.
    Massry S; Smogorzewski M
    Kidney Int Suppl; 2001 Feb; 78():S195-6. PubMed ID: 11169010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function.
    Alexiewicz JM; Kumar D; Smogorzewski M; Klin M; Massry SG
    Ann Intern Med; 1995 Dec; 123(12):919-24. PubMed ID: 7486486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of treatment of hemodialysis patients with nifedipine on metabolism and function of polymorphonuclear leukocytes.
    Alexiewicz JM; Smogorzewski M; Klin M; Akmal M; Massry SG
    Am J Kidney Dis; 1995 Mar; 25(3):440-4. PubMed ID: 7872322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of [Ca2+]i of renal proximal tubular cells and down-regulation of mRNA of PTH-PTHrP, V1a and AT1 receptors in kidney of diabetic rats.
    Marcinkowski W; Zhang G; Smogorzewski M; Massry SG
    Kidney Int; 1997 Jun; 51(6):1950-5. PubMed ID: 9186888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated cytosolic calcium and impaired proliferation of B lymphocytes in type II diabetes mellitus.
    Alexiewicz JM; Kumar D; Smogorzewski M; Massry SG
    Am J Kidney Dis; 1997 Jul; 30(1):98-104. PubMed ID: 9214407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of L- and N-type calcium channel blocker on glucose and lipid metabolism and renal function in patients with hypertension and type II diabetes mellitus.
    Masuda T; Ogura MN; Moriya T; Takahira N; Matsumoto T; Kutsuna T; Hara M; Aiba N; Noda C; Izumi T
    Cardiovasc Ther; 2011 Feb; 29(1):46-53. PubMed ID: 20337636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of elevated cytosolic calcium in the pathogenesis of complications in diabetes mellitus.
    Massry SG; Smogorzewski M
    Miner Electrolyte Metab; 1997; 23(3-6):253-60. PubMed ID: 9387128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients.
    Negro R; Hassan H
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):243-6. PubMed ID: 17318795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function in noninsulin-dependent diabetes mellitus patients treated with angiotensin-converting enzyme inhibitors and calcium channel blockers.
    Nosadini R; Brocco E; Saller A; Cernigoi AM; Abaterusso C; Bortoloso E; Dalla Vestra M; Maioli M; Piarulli F; Fioretto P
    J Hypertens Suppl; 1998 Sep; 16(4):S27-32. PubMed ID: 9817189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic treatment with amlodipine in non-insulin-dependent diabetic rats.
    Gokhale MS; Shah DH; Hakim Z; Santani DD; Goyal RK
    Pharmacol Res; 1998 Jun; 37(6):455-9. PubMed ID: 9695118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
    J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J).
    Kawamori R; Daida H; Tanaka Y; Miyauchi K; Kitagawa A; Hayashi D; Kishimoto J; Ikeda S; Imai Y; Yamazaki T
    BMC Cardiovasc Disord; 2006 Oct; 6():39. PubMed ID: 17029631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of amlodipine on insulin resistance & tumor necrosis factor-alpha levels in hypertensive obese type 2 diabetic patients.
    Ersoy C; Imamoğlu S; Budak F; Tuncel E; Ertürk E; Oral B
    Indian J Med Res; 2004 Nov; 120(5):481-8. PubMed ID: 15591634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.
    Oguzhan N; Cilan H; Sipahioglu M; Unal A; Kocyigit I; Kavuncuoglu F; Arikan T; Akpek M; Elcik D; Sahin O; Gulme E; Pala C; Tokgoz B; Utas C; Oguzhan A; Oymak O
    Ren Fail; 2013; 35(4):434-9. PubMed ID: 23413781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria.
    Fogari R; Derosa G; Zoppi A; Preti P; Lazzari P; Destro M; Fogari E; Rinaldi A; Mugellini A
    Am J Hypertens; 2007 Apr; 20(4):417-22. PubMed ID: 17386350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.